Our earlier study demonstrated that platelet activating factor (PAF) and PAFR play a significant role in ovarian cancer progression and invasion through activation of a set of tyrosine phosphor-EGFR/Src/FAK/Paxillin[15]. This evidence concerns the gene PTK2 and ovarian cancer.